Pharmafile Logo
Pharmafocus logo
Advanced Search

diabetes

Showing 15 posts of 391 posts found.

Merck acquires innovative insulin firm SmartCells

December 3, 2010
Research and Development Merck, Merck & Co, SmartCells, diabetes, insulin

Merck has bolstered its early stage diabetes portfolio with the acquisition of SmartCells, a private pharma firm that’s developing a …

News
Big Blue Test

Digital Pharma: Diabetes video goes viral

November 16, 2010
Medical Communications, Sales and Marketing Diabetes Hands Foundation, Digital Pharma blog, Roche, diabetes, viral video, youtube

An online video encouraging diabetics to test their blood sugar levels has passed 117,000 views on YouTube in just over …

News
Lilly headquarters

Lilly bolsters diagnostics presence with Avid acquisition

November 9, 2010
Research and Development Alzheimer's disease, Alzheimer’s disease, Avid Radiopharma, Eli Lilly, diabetes, emagacestat, florbetapir, lilly

Eli Lilly has acquired specialist diagnostics firm Avid Radiopharma in a deal that will bolster its diagnostics business. Philadelphia-based Avid …

News
Blog footer

Digital Pharma: Diabetes patients and Facebook

November 3, 2010
Medical Communications Digital Pharma blog, Facebook, diabetes, patient information, social networking

A quarter of comments on the 15 largest Facebook communities for diabetes patients are promotional – generally for non-FDA approved …

News
Lilly scientists

Lilly to open diabetes research centre in China

November 2, 2010
Research and Development China, Eli Lilly & Co, Lilly Research Laboratories in China, diabetes, lilly

The march of foreign pharma companies into China is to continue with Eli Lilly and Co’s opening of a diabetes …

News

Lilly suspends late-stage trials of diabetes drug Protege

October 22, 2010
Research and Development, Sales and Marketing MacroGenics, Protege, diabetes, lilly, type I diabetes

Eli Lilly and its partner MacroGenics have suspended phase III trials of their investigational type I diabetes drug Protege after …

News

Novo Nordisk invests $73m to boost diabetes drug production

October 8, 2010
Manufacturing and Production Novo Nordisk, diabetes, insulin

Novo Nordisk has announced another major expansion of its manufacturing capacity for diabetes products, setting aside $73 million to expand …

News

AZ-BMS diabetes drug impresses in phase III trials

October 1, 2010
Research and Development, Sales and Marketing AstraZeneca, BMS, dapagliflozin, diabetes

AstraZeneca and Bristol Myers Squibb’s potential first-in-class diabetes drug dapagliflozin has shown strong results in a late stage trial. It …

News

Lixisenatide shaping up to rival Victoza

September 22, 2010
Research and Development Lixisenatide, Sanofi-Aventis, diabetes

Data for Sanofi-Aventis’ injectable lixisenatide suggests it could rival Novo Nordisk’s drug Victoza.Lixisenatide is a once-daily GLP-1 receptor agonist, and …

News

Transition drops new diabetes drug

September 20, 2010
Research and Development Transition Therapeutics, diabetes, lilly

Transition Therapeutics is to abandon trials of its new diabetes treatment TT-223 following disappointing trial results. The Canadian biopharma company …

News

FDA launches safety review of Actos

September 20, 2010
Sales and Marketing Actos, Takeda, diabetes

A new safety review of Takeda’s diabetes drug Actos has been launched by the FDA after a long-term study suggested …

News
Novo Dose diabetes iPhone app

Digital Pharma: Novo launches insulin dosing app

September 17, 2010
Medical Communications, Sales and Marketing Digital Pharma blog, Novo Nordisk, app, diabetes, iphone

Novo Nordisk has launched an iPhone app for US healthcare professionals that enables to them look up dosing guidelines for …

News

Novo expands diabetes research in China

September 16, 2010
Research and Development China, Novo Nordisk, diabetes

Diabetes is at the core of Novo Nordisk’s latest investment in China, where the company plans to more than double …

News
Avandia

GSK accused of Avandia cover-up

July 14, 2010
Sales and Marketing Avandia, GlaxoSmithKline, diabetes

The ongoing battle over GlaxoSmithKline’s diabetes drug Avandia has taken another turn with US senators accusing the company of a …

News
Avastin packshot

Avandia to face European safety review

July 12, 2010
Sales and Marketing Avandia, GlaxoSmithKline, diabetes

GlaxoSmithKline’s type II diabetes drug Avandia, the subject of safety concerns since its launch in 2000, is to be reviewed …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026